EMA-话题@MedSci

#EMA#

580篇内容 | 2479人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317672, encodeId=b02e131e672c5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Eur J Haematol：多发性骨髓瘤对一线和二线治疗的反应动力学, objectType=article, longId=221129, objectId=a724221129f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a724221129f9, replyNumber=0, likeNumber=108, createdTime=2021-11-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a724221129f9, moduleTitle=Eur J Haematol：多发性骨髓瘤对一线和二线治疗的反应动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a724221129f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317671, encodeId=f843131e67114, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：基于POV的补救免疫化疗作为弥漫性大 B 细胞淋巴瘤患者的三线或以上治疗, objectType=article, longId=221086, objectId=28ac2210860c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ac2210860c, replyNumber=0, likeNumber=83, createdTime=2021-11-27, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ac2210860c, moduleTitle=Ann Hematol：基于POV的补救免疫化疗作为弥漫性大 B 细胞淋巴瘤患者的三线或以上治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ac2210860c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317670, encodeId=5a40131e67080, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Acta Haematologica：新生儿脐带血的正常值和独特的形态学特征, objectType=article, longId=220711, objectId=c89a220e1151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c89a220e1151, replyNumber=0, likeNumber=78, createdTime=2021-11-22, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c89a220e1151, moduleTitle=Acta Haematologica：新生儿脐带血的正常值和独特的形态学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c89a220e1151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317668, encodeId=c6d9131e66864, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Theramex凭借治疗绝经症状的非激素型替代药物Femarelle®进军OTC市场, objectType=article, longId=220522, objectId=d8372205226a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8372205226a, replyNumber=0, likeNumber=54, createdTime=2021-11-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8372205226a, moduleTitle=Theramex凭借治疗绝经症状的非激素型替代药物Femarelle®进军OTC市场, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8372205226a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317669, encodeId=9eef131e6692b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：急性髓系白血病早期持续存在的负面预后影响可通过在诱导后治疗前获得反应克服, objectType=article, longId=220499, objectId=69bf22049932, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69bf22049932, replyNumber=0, likeNumber=107, createdTime=2021-11-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69bf22049932, moduleTitle=HAEMATOLOGICA：急性髓系白血病早期持续存在的负面预后影响可通过在诱导后治疗前获得反应克服, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69bf22049932)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317667, encodeId=63d0131e667c5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HEMATOLOGICAL ONCOLOGY：支气管镜检查对新诊断的急性白血病患者的应用, objectType=article, longId=220342, objectId=0eee22034257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eee22034257, replyNumber=0, likeNumber=83, createdTime=2021-11-16, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eee22034257, moduleTitle=HEMATOLOGICAL ONCOLOGY：支气管镜检查对新诊断的急性白血病患者的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eee22034257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317258, encodeId=4326131e258be, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Castleman病的影像学诊断与鉴别诊断, objectType=article, longId=287427, objectId=582128e4276f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=582128e4276f, replyNumber=0, likeNumber=77, createdTime=2021-11-10, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=582128e4276f, moduleTitle=Castleman病的影像学诊断与鉴别诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=582128e4276f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317529, encodeId=0bf4131e5293a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=巨大淋巴结增生症（Castleman病）, objectType=article, longId=237268, objectId=be9c23e268af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be9c23e268af, replyNumber=0, likeNumber=42, createdTime=2021-11-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be9c23e268af, moduleTitle=巨大淋巴结增生症（Castleman病）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be9c23e268af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317664, encodeId=d8d0131e66440, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA批准Ozawade治疗白天过度嗜睡 (EDS), objectType=article, longId=219582, objectId=508a2195825c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508a2195825c, replyNumber=0, likeNumber=85, createdTime=2021-11-02, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508a2195825c, moduleTitle=EMA批准Ozawade治疗白天过度嗜睡 (EDS), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508a2195825c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317666, encodeId=a298131e666c6, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制, objectType=article, longId=219576, objectId=4e612195e65e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e612195e65e, replyNumber=0, likeNumber=72, createdTime=2021-11-02, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e612195e65e, moduleTitle=HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e612195e65e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317665, encodeId=4a6b131e6658c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：TGFβ 信号改变急性免疫反应的记忆导致骨髓衰竭, objectType=article, longId=219575, objectId=73352195e532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73352195e532, replyNumber=0, likeNumber=71, createdTime=2021-11-02, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73352195e532, moduleTitle=HAEMATOLOGICA：TGFβ 信号改变急性免疫反应的记忆导致骨髓衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73352195e532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317663, encodeId=38d3131e6633d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle= Hematol Oncol：高迁移率 A 组蛋白在血液系统恶性肿瘤中的关键作用, objectType=article, longId=218913, objectId=efd4218913a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efd4218913a6, replyNumber=0, likeNumber=79, createdTime=2021-10-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efd4218913a6, moduleTitle= Hematol Oncol：高迁移率 A 组蛋白在血液系统恶性肿瘤中的关键作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efd4218913a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317662, encodeId=1da1131e662bf, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle= J Hematol Oncol：多发性骨髓瘤患者对COVID-19 mRNA接种的反应是保守但受损的, objectType=article, longId=218812, objectId=432c2188125f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=432c2188125f, replyNumber=0, likeNumber=73, createdTime=2021-10-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=432c2188125f, moduleTitle= J Hematol Oncol：多发性骨髓瘤患者对COVID-19 mRNA接种的反应是保守但受损的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=432c2188125f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317661, encodeId=a8e5131e66117, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：伊布替尼治疗不能诱导慢性淋巴细胞白血病的TP53克隆进化, objectType=article, longId=218715, objectId=800e218e15c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=800e218e15c8, replyNumber=0, likeNumber=63, createdTime=2021-10-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=800e218e15c8, moduleTitle=HAEMATOLOGICA：伊布替尼治疗不能诱导慢性淋巴细胞白血病的TP53克隆进化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=800e218e15c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317660, encodeId=f50b131e66009, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：过氧化物酶体增殖物激活受体 α 在高脂血症下促进血小板高反应性和血栓形成中的关键作用, objectType=article, longId=218345, objectId=81c3218345f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81c3218345f8, replyNumber=0, likeNumber=100, createdTime=2021-10-11, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81c3218345f8, moduleTitle=HAEMATOLOGICA：过氧化物酶体增殖物激活受体 α 在高脂血症下促进血小板高反应性和血栓形成中的关键作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81c3218345f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317659, encodeId=539a131e659ca, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：弥漫性大b细胞淋巴瘤诊断1年后幸存者的生活质量: 一项LYSA研究, objectType=article, longId=218340, objectId=2dc9218340ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dc9218340ef, replyNumber=0, likeNumber=65, createdTime=2021-10-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dc9218340ef, moduleTitle=Ann Hematol：弥漫性大b细胞淋巴瘤诊断1年后幸存者的生活质量: 一项LYSA研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dc9218340ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317658, encodeId=3ad3131e658dc, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haemat：瘤内注射TTI-621治疗复发性或难治性蕈样真菌病或Sézary综合征的安全性, objectType=article, longId=218260, objectId=769721826066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=769721826066, replyNumber=0, likeNumber=61, createdTime=2021-10-10, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=769721826066, moduleTitle=Lancet Haemat：瘤内注射TTI-621治疗复发性或难治性蕈样真菌病或Sézary综合征的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=769721826066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317657, encodeId=6832131e657b6, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：胸腺MALT淋巴瘤的分子遗传学和临床病理特征, objectType=article, longId=218248, objectId=82d1218248cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82d1218248cd, replyNumber=0, likeNumber=81, createdTime=2021-10-10, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82d1218248cd, moduleTitle=Ann Hematol：胸腺MALT淋巴瘤的分子遗传学和临床病理特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82d1218248cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317656, encodeId=e969131e656c8, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, objectType=article, longId=218057, objectId=abc921805e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abc921805e25, replyNumber=0, likeNumber=43, createdTime=2021-10-04, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abc921805e25, moduleTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abc921805e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317655, encodeId=c767131e65513, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后, objectType=article, longId=218055, objectId=1a5821805589, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a5821805589, replyNumber=0, likeNumber=92, createdTime=2021-10-04, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a5821805589, moduleTitle=Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a5821805589)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Eur J Haematol：多发性骨髓瘤对一线和二线治疗的反应动力学

2021-11-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：基于POV的补救免疫化疗作为弥漫性大 B 细胞淋巴瘤患者的三线或以上治疗

2021-11-27

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Acta Haematologica：新生儿脐带血的正常值和独特的形态学特征

2021-11-22

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Theramex凭借治疗绝经症状的非激素型替代药物Femarelle®进军OTC市场

2021-11-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：急性髓系白血病早期持续存在的负面预后影响可通过在诱导后治疗前获得反应克服

2021-11-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HEMATOLOGICAL ONCOLOGY：支气管镜检查对新诊断的急性白血病患者的应用

2021-11-16

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Castleman病的影像学诊断与鉴别诊断

2021-11-10

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

巨大淋巴结增生症（Castleman病）

2021-11-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA批准Ozawade治疗白天过度嗜睡 (EDS)

2021-11-02

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制

2021-11-02

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：TGFβ 信号改变急性免疫反应的记忆导致骨髓衰竭

2021-11-02

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Hematol Oncol：高迁移率 A 组蛋白在血液系统恶性肿瘤中的关键作用

2021-10-21

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：多发性骨髓瘤患者对COVID-19 mRNA接种的反应是保守但受损的

2021-10-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：伊布替尼治疗不能诱导慢性淋巴细胞白血病的TP53克隆进化

2021-10-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：过氧化物酶体增殖物激活受体 α 在高脂血症下促进血小板高反应性和血栓形成中的关键作用

2021-10-11

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：弥漫性大b细胞淋巴瘤诊断1年后幸存者的生活质量: 一项LYSA研究

2021-10-11

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haemat：瘤内注射TTI-621治疗复发性或难治性蕈样真菌病或Sézary综合征的安全性

2021-10-10

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：胸腺MALT淋巴瘤的分子遗传学和临床病理特征

2021-10-10

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！

2021-10-04

柳叶一刀 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后

2021-10-04

科室
- - 订阅+
  - 更多科室
工具
服务